Literature DB >> 20525033

Improving PTSD/substance abuse treatment in the VA: a survey of providers.

Lisa M Najavits1, Sonya B Norman, Daniel Kivlahan, Thomas R Kosten.   

Abstract

We surveyed 205 Veterans Affairs (VA) staff on treatment of posttraumatic stress disorder (PTSD), substance use disorder (SUD), and the combination (PTSD/SUD). The survey was anonymous and VA-wide. PTSD/SUD was perceived as more difficult to treat than either disorder alone; gratification in the work was stronger than difficulty (for PTSD, SUD, and PTSD/SUD); and difficulty and gratification appeared separate constructs. Respondents endorsed views that represent expert treatment for the comorbidity; however, there was also endorsement of "myths." Thus, there is a need for more training, policy clarifications, service integration, and adaptations for veterans returning from Iraq and Afghanistan. Limitations are described.

Entities:  

Mesh:

Year:  2010        PMID: 20525033     DOI: 10.1111/j.1521-0391.2010.00039.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  11 in total

1.  The impact of substance use disorders on treatment engagement among justice-involved veterans with posttraumatic stress disorder.

Authors:  Matthew A Stimmel; Joel Rosenthal; Jessica Blue-Howells; Sean Clark; Alex H S Harris; Anna D Rubinsky; Thomas Bowe; Andrea K Finlay
Journal:  Psychol Serv       Date:  2018-04-30

Review 2.  Piloting cognitive-behavioral therapy for insomnia integrated with prolonged exposure.

Authors:  Peter J Colvonen; Sean P A Drummond; Abigail C Angkaw; Sonya B Norman
Journal:  Psychol Trauma       Date:  2018-09-13

3.  Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Santiago Papini; Therese Killeen; Sudie E Back; Denise A Hien
Journal:  Psychother Psychosom       Date:  2017-05-11       Impact factor: 17.659

Review 4.  Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.

Authors:  Therese K Killeen; Sudie E Back; Kathleen T Brady
Journal:  Drug Alcohol Rev       Date:  2015-03-04

5.  A pilot study of seeking safety therapy with OEF/OIF veterans.

Authors:  Sonya B Norman; Kendall C Wilkins; Susan F Tapert; Ariel J Lang; Lisa M Najavits
Journal:  J Psychoactive Drugs       Date:  2010-03

6.  Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.

Authors:  Christal L Badour; Julianne C Flanagan; Nicholas P Allan; Amanda K Gilmore; Daniel F Gros; Therese Killeen; Kristina J Korte; Delisa G Brown; Kateryna Kolnogorova; Sudie E Back
Journal:  J Trauma Stress       Date:  2021-11-13

7.  To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD.

Authors:  Brian E Lozano; Daniel F Gros; Therese Killeen; Maryanne Jaconis; Francis M Beylotte; Stephen Boyd; Sudie E Back
Journal:  Am J Addict       Date:  2015-08-24

8.  Cognitive processing therapy for veterans with comorbid PTSD and alcohol use disorders.

Authors:  Debra Kaysen; Jeremiah Schumm; Eric R Pedersen; Richard W Seim; Michele Bedard-Gilligan; Kathleen Chard
Journal:  Addict Behav       Date:  2013-08-24       Impact factor: 3.913

9.  Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Authors:  Peter J Colvonen; Guadalupe L Rivera; Laura D Straus; Jae E Park; Moira Haller; Sonya B Norman; Sonia Ancoli-Israel
Journal:  Psychol Trauma       Date:  2021-09-02

10.  Why clinicians do not implement integrated treatment for comorbid substance use disorder and posttraumatic stress disorder: a qualitative study.

Authors:  Nele Gielen; Anja Krumeich; Remco C Havermans; Feikje Smeets; Anita Jansen
Journal:  Eur J Psychotraumatol       Date:  2014-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.